600789 Shandong Lukang Pharmaceutical
- 7.00
- +0.06+0.86%
Shandong Lukang Pharmaceutical News
Shandong Lukang Pharmaceutical's Announcement on the Completion of Land Transfer Procedures and Progress in the South Plant Area
Shandong Lukang Pharmaceutical's Announcement Regarding Government Subsidies Received
Shandong Lukang Pharmaceutical Announcement of Annual Equity Distribution in 2023
Shandong Lukang Pharmaceutical's announcement regarding the adjustment of the exercise price of the 2019 stock options compensation plan.
Legal Opinion of Beijing Tongshang Law Firm on the Adjustment of the 2019 Stock Option Incentive Plan Exercise Price of Shandong Lukang Pharmaceutical Co., Ltd.
Announcement of the resolution of the second (special) meeting of the eleventh board of directors of Shandong Lukang Pharmaceutical.
Announcement of the resolution of the 11th Supervisory Board of Shandong Lukang Pharmaceutical Co., Ltd. Second (Extraordinary) Meeting
Announcement from Shandong Lukang Pharmaceutical regarding the approval of the market application for non-budesonide active pharmaceutical ingredient.
Announcement of Lukang Pharmaceutical on obtaining a drug registration certificate for its holding subsidiary
An indicative announcement by Lu Kang Pharmaceutical on the period during which the stock option incentive plan restricts the exercise of rights
Announcement of Lukang Pharmaceutical on the consistency evaluation of cefadroxil capsules as generic drugs
Response letter from Hualu Holding Group Co., Ltd. regarding abnormal fluctuations in the stock trading of Shandong Lukang Pharmaceutical Co., Ltd.
Announcement on abnormal fluctuations in stock trading of Lukang Pharmaceutical
Announcement of Lukang Pharmaceutical on holding a performance briefing for the first quarter of 2023 and 2024
Response letter from Hualu Holding Group Co., Ltd. regarding abnormal fluctuations in the stock trading of Shandong Lukang Pharmaceutical Co., Ltd.
Announcement on abnormal fluctuations in stock trading of Lukang Pharmaceutical
Lukang Pharmaceutical Report for the First Quarter of 2024
Legal Opinion of Beijing Commerce Law Firm on the 2023 Annual General Meeting of Shareholders of Shandong Lukang Pharmaceutical Co., Ltd.
Announcement of Resolutions of the First Meeting of the 11th Board of Directors of Lukang Pharmaceutical
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Lukang Pharmaceutical
Analysis
Price Target
No Data
